L3VLUP
ProSign in

VRDN in the 13F filings

Viridian Therapeutics Inc · CUSIP 92790C104

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2025
the date the book describes
Filed
19 Feb 2026
latest of these filings; the earliest 10 Feb 2026
Managers listing it
28
at least, of 95 tracked, among listed positions
Comparable managers
92
filed both Q3 2025 and Q4 2025; 1 listed it in both
Shares listed
28,369,553
combined, among listed positions
Reported value
$883m
combined, at the quarter end

Among the 92 comparable managers: 25 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +5,734,866.

Managers listing VRDN in Q4 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

28 of 28 holders

ActionFiling
Fidelity (FMR LLC)14,384,456$448munder 0.1%Added+2,135,10117 Feb 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc3,439,414$107munder 0.1%Added+1,021,31017 Feb 2026 (the filing on sec.gov)
Wellington Management Group LLP1,971,411$61munder 0.1%Added+848,87917 Feb 2026 (the filing on sec.gov)
AllianceBernstein LP1,414,181$44munder 0.1%Trimmed-445,27717 Feb 2026 (the filing on sec.gov)
Marshall Wace LLP1,375,739$43munder 0.1%Added+506,55113 Feb 2026 (the filing on sec.gov)
Woodline Partners LP1,115,929$35m0.13%Added+300,44417 Feb 2026 (the filing on sec.gov)
D. E. Shaw & Co.1,000,717$31munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Citadel Advisors LLC679,694$21munder 0.1%Added+602,32117 Feb 2026 (the filing on sec.gov)
Balyasny Asset Management LLC503,868$16munder 0.1%Added+301,04717 Feb 2026 (the filing on sec.gov)
Millennium Management LLC460,125$14munder 0.1%Added+323,84517 Feb 2026 (the filing on sec.gov)
Arrowstreet Capital LP341,258$11munder 0.1%Newnew13 Feb 2026 (the filing on sec.gov)
Jane Street Group LLC279,607$8.7munder 0.1%Added+244,19312 Feb 2026 (the filing on sec.gov)
Point72 Asset Management LP254,285$7.9munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC217,434$6.6munder 0.1%Added+159,50617 Feb 2026 (the filing on sec.gov)
Invesco Ltd183,468$5.7munder 0.1%Added+102,67619 Feb 2026 (the filing on sec.gov)
Hudson Bay Capital Management LP151,464$4.7munder 0.1%Trimmed-23,78713 Feb 2026 (the filing on sec.gov)
Moore Capital Management LP150,000$4.7m0.07%Newnew17 Feb 2026 (the filing on sec.gov)
Susquehanna International Group LLP116,524$3.6munder 0.1%Added+78,88417 Feb 2026 (the filing on sec.gov)
ExodusPoint Capital Management LP92,697$2.9munder 0.1%Added+78,28417 Feb 2026 (the filing on sec.gov)
Walleye Capital LLC60,842$1.9munder 0.1%Added+10,19913 Feb 2026 (the filing on sec.gov)
Tudor Investment Corp51,597$1.6munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Verition Fund Management LLC45,072$1.4munder 0.1%Added+34,75213 Feb 2026 (the filing on sec.gov)
Janus Henderson Group Ltd27,472$854kunder 0.1%Held017 Feb 2026 (the filing on sec.gov)
Man Group PLC18,200$566kunder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Brevan Howard Capital Management LP17,550$546kunder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Page 1 of 2

Largest increases and reductions, by shares

Q3 2025 to Q4 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (10)

Exited (2)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
5 in Q3 2024 to 3 in Q2 2026

Tracked managers listing it, at least.

024620222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
VRDN by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20211$10mn.a.n.a.
Q4 20212$7.3mn.a.n.a.
Q1 20222$7.1mn.a.n.a.
Q2 20222$8.5mn.a.n.a.
Q3 20222$10.0mn.a.n.a.
Q4 20225$38mn.a.n.a.
Q1 20231$3.0mn.a.n.a.
Q2 20232$8.9mn.a.n.a.
Q3 20231$366kn.a.n.a.
Q4 20231$51m11
Q1 20242$55m20
Q2 20242$48m11
Q3 20245$92m32
Q4 20243$68m12
Q1 20252$39m10
Q2 20252$43m20
Q3 20252$65m01
Q4 20254$89m254
Q1 20263$65m1120
Q2 20263$70m1311

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

VRDN and LLY →VRDN and JNJ →VRDN and VRTX →Choose a stock to compare with VRDN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own VRDN, latest filings →Back to the 13F Explorer →